Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Hypertension ; 57(5): 965-72, 2011 May.
Artigo em Inglês | MEDLINE | ID: mdl-21422380

RESUMO

Angiotensin (Ang) I-converting enzyme (ACE) is involved in the control of blood pressure by catalyzing the conversion of Ang I into the vasoconstrictor Ang II and degrading the vasodilator peptide bradykinin. Human ACE also functions as a signal transduction molecule, and the binding of ACE substrates or its inhibitors initiates a series of events. In this study, we examined whether Ang II could bind to ACE generating calcium signaling. Chinese hamster ovary cells transfected with an ACE expression vector reveal that Ang II is able to bind with high affinity to ACE in the absence of the Ang II type 1 and type 2 receptors and to activate intracellular signaling pathways, such as inositol 1,4,5-trisphosphate and calcium. These effects could be blocked by the ACE inhibitor, lisinopril. Calcium mobilization was specific for Ang II, because other ACE substrates or products, namely Ang 1-7, bradykinin, bradykinin 1-5, and N-acetyl-seryl-aspartyl-lysyl-proline, did not trigger this signaling pathway. Moreover, in Tm5, a mouse melanoma cell line endogenously expressing ACE but not Ang II type 1 or type 2 receptors, Ang II increased intracellular calcium and reactive oxygen species. In conclusion, we describe for the first time that Ang II can interact with ACE and evoke calcium and other signaling molecules in cells expressing only ACE. These findings uncover a new mechanism of Ang II action and have implications for the understanding of the renin-Ang system.


Assuntos
Angiotensina II/metabolismo , Sinalização do Cálcio/fisiologia , Peptidil Dipeptidase A/metabolismo , Análise de Variância , Inibidores da Enzima Conversora de Angiotensina/farmacologia , Animais , Células CHO , Sinalização do Cálcio/efeitos dos fármacos , Células Cultivadas , Cricetinae , Cricetulus , Citometria de Fluxo , Lisinopril/farmacologia , Camundongos , Espécies Reativas de Oxigênio/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa
2.
Int J Radiat Biol ; 84(11): 937-44, 2008 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-19016142

RESUMO

PURPOSE: The vasoactive octapeptide hormone angiotensin II (DRVYIHPF, AngII) was selected as the target of this2investigation, which was aimed at determining the effect of gamma radiation on peptide structure and biological activity. MATERIALS AND METHODS: Radiation doses ranging from 1-15 kGy were applied to samples of purified AngII. RESULTS: The measured amount of remaining native hormone decreased non-linearly as the gamma radiation dose increases. Amino acid analysis of these irradiated peptide solutions demonstrated similar, simultaneous modifications of Phe8 and His6 residues along with the increase in the radiation dose. This structural variation of the vasoactive peptide closely resembled the decreasing process of the biological potencies of irradiated peptide solutions in rat uterus and guinea pig ileum muscle preparations. CONCLUSIONS: These findings suggest that investigating the effect of gamma radiation on small model molecules such as peptides could be of value for further extending this type of study to other physiologically relevant macromolecules such as proteins. Of note, this unique approach could also be useful in generating different types of peptide analogs (after purification) for application in future classical structure-function studies.


Assuntos
Angiotensina II/química , Angiotensina II/metabolismo , Raios gama , Animais , Cromatografia Líquida de Alta Pressão , Relação Dose-Resposta à Radiação , Feminino , Cobaias , Íleo/metabolismo , Íleo/efeitos da radiação , Ratos , Útero/metabolismo , Útero/efeitos da radiação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA